INVO Fertility, Inc.
IVFdata completeness 88%15 fiscal years on fileINVO Fertility, Inc. earns about -239% on invested capital, and has bought back 99% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $4.16M1 | $822,1962 | $3.02M3 | $6.56M3 | $6.84M4 |
| Net income | −$6.65M5 | −$10.9M6 | −$8.03M7 | −$9.26M8 | −$23.3M8 |
| Operating cash flow | −$6.03M9 | −$6.6M10 | −$4.76M11 | −$2.97M12 | −$7.01M12 |
| Capital expenditure | $415,71013 | $10,78514 | $444,72215 | $183,70316 | $43,41216 |
| Free cash flow (derived) | −$6.45M9 | −$6.61M10 | −$5.2M11 | −$3.16M12 | −$7.06M12 |
| Total debt | — | — | — | $7.47M17 | $2.91M17 |
| Cash & equivalents | $5.68M18 | — | — | — | — |
| Diluted shares | 10.6M | 606,130 | 119,264 | 2,514 | 117,083 |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $617.02 of net worth that earned you −$1,992.01 and generated −$602.81 of cash last year, against $248.7 of debt.
It earned an average -239% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 99% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has fallen 61% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012532 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K/A · period ending 2022-12-31 · accession 0001493152-24-046808 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-006726 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2025-12-31 · accession 0001493152-26-026775 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012532 (NetIncomeLoss)
- 10-K/A · period ending 2022-12-31 · accession 0001493152-24-046808 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-006726 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-026775 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012532 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2022-12-31 · accession 0001493152-24-046808 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-006726 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-026775 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012532 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K/A · period ending 2022-12-31 · accession 0001493152-24-046808 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-006726 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-026775 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-026775 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001493152-22-008421 (CashAndCashEquivalentsAtCarryingValue)